If any of the following side effects occur while taking alemtuzumab, check with your doctor or nurse immediately:
Median CD4+ lymphocyte counts were 2/mcL 4 weeks after begin of alemtuzumab (the active ingredient contained in Lemtrada) therapy, 207/mcL two months after discontinuation, and 470/mcL six months after discontinuation.
CD8+ cells followed a similar pattern of change.
In some patients, CD4+ and CD8+ counts did not return to baseline levels within 1 year after discontinuation.
Very common (10% or more): Lymphopenia (97%), neutropenia (77%), anemia (76%), thrombocytopenia (71%), granulocytopeniaCommon (1% to 10%): Decrease in CD4 lymphocytes, decrease in CD8 lymphocytes, decrease in T-lymphocyte count, febrile neutropenia, pancytopenia, leukopenia, lymphopenia, purpuraUncommon (0.
1% to 1%): Aplasia bone marrow, disseminated intravascular coagulation, hemolytic anemia, decreased haptoglobin, bone marrow depression, hematology test abnormal
Very common (10% or more): Immunogenicity (up to 83%), herpes viral infection (16%), fungal infection (13%), sepsis, cytomegalovirus infection, cytomegalovirusviremiaCommon (1% to 10%): Influenza, neutropenic feverUncommon (0.
1% to 1%): Sepsis, staphylococcal bacteremia, tuberculosis, beta hemolytic streptococcal infections, candidiasis, genital candidiasis, body tineaVery rare (less than 0.
01%): Immune thrombocytopeniaFrequency not reported: Autoimmunity
Types of infections reported in the 93 B-CLL patients have included Candida, CMV, Aspergillosis, Mucormycosis, Cryptococcal pneumonia, Listeria monocytogenes meningitis, disseminated Herpes zoster, Herpes simplex, Torulopsis pneumonia, and PCP pneumonia.
Infections reported in other trials have included abscess, bacterial infection, Herpes zoster infection, Pneumocystis carinii infection, otitis media, Tuberculosis infection, interstitial pneumonitis, progressive multifocal leukoencephalopathy, and other viral infections.
Postmarketing experiences have included Epstein-Barr virus lymphoproliferative disorder and reactivation of latent viruses.
An initial dose of 80 mg caused acute bronchospasm, cough, shortness of breath, followed by anuria and death in one patient.
Tumor lysis syndrome may have been a factor.
Very common (10% or more): Nasopharyngitis (25%), upper respiratory tract infection (16%), sinusitis (11%), pneumoniaCommon (1% to 10%): Cough, dyspnea, bronchitis, chest discomfort, epistaxis, hypoxia, hemoptysis, bronchospasmUncommon (0.
1% to 1%): Stridor, throat tightness, pulmonary infiltration, pleural effusion, breath sounds decreased, respiratory disorderFrequency not reported: Respiratory alkalosis
Very common (10% or more): Nausea (21%), diarrhea (12%), oropharyngeal pain (11%), abdominal pain (10%), vomiting (10%)Common (1% to 10%): Dyspepsia, gastrointestinal hemorrhage, ulcerative stomatitis, stomatitis, gastroenteritis, tongue ulceration, gingivitis, hiccup, eructation, dyspepsia, constipation, flatulence, oral candidiasisUncommon (0.
1% to 1%): Gingival bleeding, dry mouth, paralytic ileus, oral discomfortFrequency not reported: Duodenal ulcer, intestinal perforation, melena, peptic ulcer, pseudomembranous colitis, colitis, pancreatitis, peritonitis
Very common (10% or more): Headache (52%), insomnia (16%), paresthesia (10%), dizziness (10%)Common (1% to 10%): Dysgeusia, vertigo, tremor, paresthesia, hypoesthesia, hyperkinesia, taste loss Uncommon (0.
1% to 1%): Syncope, abnormal gait, dystonia, hyperesthesia, neuropathy, taste perversion
Very common (10% or more): Hypotension, hypertensionCommon (1% to 10%): Tachycardia, peripheral edema, vasospasmUncommon (0.
1% to 1%): Cardiac arrest, myocardial infarction, atrial fibrillation, supraventricular tachycardia, arrhythmia, bradycardia, abnormal ECG, peripheral ischemia, cyanosis, orthostatic hypotension, hot flushFrequency not reported: Congestive heart failure, cardiomyopathy, decreased ejection fraction in non-MS patients previously treated with potentially cardiotoxic agents
Very common (10% or more): Arthralgia (12%), pain in extremity (12%), back pain (12%)Common (1% to 10%): Chills, muscular weakness, muscle spasms, myalgia, neck pain, arthralgia, skeletal pain, back painUncommon (0.
1% to 1%): Leg pain, hypertonia, muscle spasmsFrequency not reported: Arthritis or worsening arthritis, bone fracture, myositis, muscle atrophy, osteomyelitis, polymyositis, skeletal pain
Common (1% to 10%): Anxiety, confusion, depression, somnolenceUncommon (0.
1% to 1%): Suicidal behavior or ideation, depersonalization, personality disorder, abnormal thinking, nervousness, apathy
Very common (10% or more): Rash (53%), urticaria (16%), pruritus (14%)Common (1% to 10%): Dermatitis, erythema, hyperhidrosis, bullous eruption, erythematous rashUncommon (0.
1% to 1%): Maculopapular rash, skin disorder
Very common (10% or more): Thyroid gland disorders (13%)
Frequency not reported: Hyperbilirubinemia, hepatic failure, hepatocellular damage, hypoalbuminemia, biliary pain
Very common (10% or more): AnorexiaCommon (1% to 10%): hyponatremia, hypocalcemia, weight decrease, dehydration, thirstUncommon (0.
1% to 1%): Hypokalemia, diabetes mellitus aggravatedFrequency not reported: Thyroid disorder, fluid overload
Frequency not reported: Malignancies (e.
g.
, malignant lymphoma, malignant testicular neoplasm, prostatic cancer, plasma cell dyscrasias, secondary leukemia, squamous cell carcinoma)
Very common (10% or more): Urinary tract infection (19%)Common (1% to 10%): Blood in urine, abnormal uterine bleedingUncommon (0.
1% to 1%): Impotence, urinary incontinence, urine flow decreased, polyuria, cystitisFrequency not reported: Cervical dysplasia
Very common (10% or more): Pyrexia (29%), fatigue (18%), flushing (10%)Common (1% to 10%): Asthenia
Uncommon (0.
1% to 1%): Renal function abnormalFrequency not reported: Acute renal failure
Common (1% to 10%): ConjunctivitisUncommon (0.
1% to 1%): Endophthalmitis
Uncommon (0.
1% to 1%): Allergic reactionFrequency not reported: Anaphylactoid reaction
Uncommon (0.
1% to 1%): Infusion site bruising, infusion site dermatitis, infusion site painFrequency not reported: Infusion reactions
Black, tarry stools
blood in the urine
chills
cough
diarrhea
dizziness
faintness, or lightheadedness when getting up suddenly from a lying or sitting position
fast heartbeat
fever
headache
itching, hives, or rash
nausea and vomiting
painful or difficult urination
pale skin
sore throat
sores, ulcers, or white spots on the lips or in the mouth
sweating
swollen glands
tightness in the chest
troubled breathing, exertional
unusual bleeding or bruising
unusual tiredness or weakness
Bloating or swelling of the face, hands, lower legs, or feet
chest pain
hoarseness
lower back or side pain
muscle weakness
pounding, or irregular heartbeat or pulse
rapid weight gain
red or purple spots on the skin, varying in size and remaining after pushing the skin surface
Flushing of the face or neck
swelling of the eyelids, face, or lips
white patches on the tongue, in the mouth, or in folds of the skin, including the genitals
Back pain
blindness
blurred vision
chest discomfort
confusion
convulsions
decreased urine output
decreased vision
dilated neck veins
drowsiness
extreme fatigue
eye pain
feeling of discomfort
inability to move the arms and legs
inflammation of the joints
irregular breathing
joint pain, stiffness, or swelling
muscle aches or pain
numbness, pain, tingling, or weakness
painful glands
spitting up blood
sudden numbness and weakness in the arms and legs
swelling of the face, fingers, feet, or lower legs
Fear or nervousness
trouble sleeping
Acid or sour stomach
belching
bone pain
burning, crawling, itching, numbness, prickling, “pins and needles”, or tingling feelings
heartburn
indigestion
lack or loss of strength
loss of appetite
painful cold sores or blisters on the lips, nose, eyes, or genitals
stomach discomfort, upset, or pain
swelling or inflammation of the mouth
weight loss
Bloody nose
constipation
sensation of temperature change
sleepiness
stuffy nose
tremor
unexplained nosebleeds